SHANDONG XINHUA - Announcement of Shandong Xinhua Pharmaceutical Co., Ltd. on holding the 2025 online performance briefing
SHANDONG XINHUA - An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement and make no representation as to its accuracy or completeness. statement and expressly disclaims any liability for any loss arising from or arising from reliance on the whole or any part of the contents of this announcement.
Shandong Xinhua Pharmaceutical Co., Ltd. Shandong Xinhua Pharmaceutical Company Limited
(a joint stock limited company incorporated in the People's Republic of China) (Stock code: 00719)
Overseas regulatory announcement
This announcement is made in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
Shandong Xinhua Pharmaceutical Co., Ltd. (the "Company") will be on the cninfo.com on April 28, 2026 The company's "Announcement on Holding the 2025 Online Performance Briefing Meeting" published on (http://www.cninfo.com.cn) is hereby set out
The Chinese version of the relevant documents is available for reference.
By order of the board of directors Shandong Xinhua Pharmaceutical Co., Ltd. He Tongqing
Chairman
Zibo, China April 27, 2026
As at the date of this announcement, the members of the Board of Directors of the Company are as follows:
Executive Director: Independent Non-Executive Director:
Mr. He Tongqing (Chairman) Mr. Pan Guangcheng Mr. Xu Wenhui Mr. Zhu Jianwei Mr. Hou Ning Mr. Ling Peixue Ms. Zhang Jingjing
Non-executive Directors: Mr. Zhang Chengyong
Securities code: 000756 Securities abbreviation: Xinhua Pharmaceutical Announcement number: 2026-23
Shandong Xinhua Pharmaceutical Co., Ltd.
Announcement on holding the 2025 online performance briefing
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and there are no false records, misleading statements or
Major omissions.
Shandong Xinhua Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") has announced on cninfo.com on March 30, 2026
The "2025 Annual Report" and "2025 Annual Report Summary" were disclosed on (www.cninfo.com.cn). For the convenience of investors
To have a more comprehensive and in-depth understanding of the company's operating performance, development strategy, etc., the company will hold a conference on May 9, 2026 (Saturday) from 9:00-10:00
The company's 2025 online performance briefing will be held on "Value Online" (www.ir-online.cn) to communicate and communicate with investors.
Listen extensively to investors’ opinions and suggestions.
- How to participate in the meeting
This annual performance briefing will be held in an interactive online manner. Investors can attend the meeting on May 9, 2026 (Saturday)
9:00-10:00 You can enter and participate in the interaction through the website https://eseb.cn/1xv1CYwovbq or use WeChat to scan the mini program code below
Active communication.
- Attendees
Personnel attending this online performance briefing include: Chairman Mr. He Tongqing, Director and General Manager Mr. Xu Wenhui, Director and Finance
Mr. Hou Ning, the person in charge, Mr. Pan Guangcheng, Mr. Zhu Jianwei, Mr. Ling Peixue and Ms. Zhang Jingjing, independent directors, Cao Changqiu, secretary of the board of directors
Sir. If there are special circumstances, the company will adjust the attendance according to the actual situation.
- Collection of meeting questions
In order to fully respect investors and improve the efficiency and pertinence of communication between the company and investors, the company’s 2025 online performance is now discussed
Questions will be collected from investors in advance. Investors can visit the website before May 6, 2026 (Wednesday)
https://eseb.cn/1xv1CYwovbq or use WeChat to scan the mini program code above to ask questions before the meeting. The company will use this performance report to
At the meeting tomorrow, we will answer questions of common concern to investors within the scope of information disclosure.
- Other matters
After the performance briefing is held, investors can view the results through Value Online (www.ir-online.cn) or the Yidong app.
The convening situation and main content of the performance briefing meeting.
Announcement is hereby made.
Board of Directors of Shandong Xinhua Pharmaceutical Co., Ltd. April 27, 2026